Evaxion A (EVAX) Research & Development (2020 - 2026)
Evaxion A's Research & Development was -$2.33 million in Q2 2026, compared with -$2.17 million a year earlier.
Powered by 
Analysis
Evaxion A (EVAX) Research & Development (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Evaxion A's Research & Development was -$10.28 million through Jun 30, 2026; for FY2025, it was -$9.98 million.
- In earlier years, Research & Development was -$10.46 million in FY2024, -$11.92 million in FY2023, -$17.06 million in FY2022 and -$19.58 million in FY2021.
- Quarterly Research & Development has moved between -$6.15 million (Q4 2021) and $4.8 million (Q1 2022) over five years.
- Per Business Quant data, EVAX's Research & Development in the three quarters before Q2 2026 was -$2.3 million (Q1 2026), -$2.56 million (Q4 2025) and -$3.09 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Evaxion A | 26.27 Mn | -39.97 Mn | - | 2.33 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.33 Mn |
| Mar 31, 2026 | -2.30 Mn |
| Dec 31, 2025 | -2.56 Mn |
| Sep 30, 2025 | -3.09 Mn |
| Jun 30, 2025 | 2.17 Mn |
| Mar 31, 2025 | -2.16 Mn |
| Dec 31, 2024 | -2.26 Mn |
| Sep 30, 2024 | -2.61 Mn |
| Jun 30, 2024 | 2.75 Mn |
| Mar 31, 2024 | -2.84 Mn |
| Dec 31, 2023 | -2.30 Mn |
| Sep 30, 2023 | -2.83 Mn |
| Jun 30, 2023 | 2.94 Mn |
| Mar 31, 2023 | -3.85 Mn |
| Dec 31, 2022 | -4.07 Mn |
| Sep 30, 2022 | 4.07 Mn |
| Jun 30, 2022 | 4.11 Mn |
| Mar 31, 2022 | 4.80 Mn |
| Sep 30, 2021 | 4.42 Mn |
| Jun 30, 2021 | 5.11 Mn |
API Access
Evaxion A Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=EVAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "EVAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=EVAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();